| Name | GLP-1 receptor agonist 8 |
|---|---|
| Synonyms |
GLP-1 rector agonist 8
1H-Benzimidazole-6-cboxylic acid, 2-[[4-[(2R)-2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-, ammonium salt (1:1) |
| Description | GLP-1 receptor agonist 8 is a potent agonist of GLP-1 R. GLP-1 receptor agonist 8 has the potential for the research of diabetes, obesity, and nonalcoholic fatty liver disease (NAFLD) (extracted from patent WO2019239319A1, compound 17)[1]. |
|---|---|
| Related Catalog | |
| Target |
GLP-1 R[1] |
| References |
[1]. Gary Erik Aspnes, et al. Glp-1 receptor agonists and uses thereof. Patent WO2019239319A1. |
| Molecular Formula | C34H36ClFN6O4 |
|---|---|
| Molecular Weight | 647.14 |